Baylor College of Medicine: Researchers Discover Positive Effects of Intravenous Ketamine for Treatment-Resistant Depression
May 26, 2023
May 26, 2023
HOUSTON, Texas, May 26 (TNSjou) -- The Baylor College of Medicine issued the following news:
Electroconvulsive therapy (ECT) is considered to be the gold standard to treat an episode of refractory depression. However, over the last decade, ketamine has proved itself as a rapid-acting and effective treatment option as well. Researchers from Baylor College of Medicine and the Michael E. DeBakey Department of Veterans Affairs Medical Center studied whether ketamine was noninferior to E . . .
Electroconvulsive therapy (ECT) is considered to be the gold standard to treat an episode of refractory depression. However, over the last decade, ketamine has proved itself as a rapid-acting and effective treatment option as well. Researchers from Baylor College of Medicine and the Michael E. DeBakey Department of Veterans Affairs Medical Center studied whether ketamine was noninferior to E . . .